The future of antibody therapy in chronic lymphocytic leukemia.

Published in: Expert opinion on emerging drugs (2021)

While anti-CD20 antibodies have played a pivotal role in the treatment of CLL, additional studies will be required to determine the optimal application of these therapies in combination with targeted therapy.

Keyphrases

chronic lymphocytic leukemia
current status
combination therapy
cell therapy
nk cells